Naxitamab-related adverse events within and across treatment cycles in patients with relapsed/refractory (R/R) high-risk neuroblastoma Meeting Abstract
| Authors: | Mora, J.; Chan, G. C.; Morgenstern, D. A.; Amoroso, L.; Nysom, K.; Faber, J.; Wingerter, A.; Bear, M.; Rubio-San-Simón, A.; Eldridge, J.; Tornøe, K.; Düring, M.; Kushner, B. H. |
| Abstract Title: | Naxitamab-related adverse events within and across treatment cycles in patients with relapsed/refractory (R/R) high-risk neuroblastoma |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557402314 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.10032 |
| Notes: | Meeting Abstract: 10032 -- Source: Wos |
